RNA

49.77

1.97% -1.00

Vorhandelsmarkt: 49.82 0.05 +0.10%

Avidity Biosciences Inc (RNA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$50.77

Offen:

$51

24-Stunden-Volumen:

2.24M

Relative Volume:

0.71

Marktkapitalisierung:

$7.26B

Einnahmen:

$10.12M

Nettoeinkommen (Verlust:

$-280.49M

KGV:

-17.22

EPS:

-2.89

Netto-Cashflow:

$-188.51M

1W Leistung:

+5.89%

1M Leistung:

+7.26%

6M Leistung:

+106.43%

1J Leistung:

+12.55%

1-Tages-Spanne:

$49.46

$52.17

1-Wochen-Bereich:

$45.16

$52.17

52-Wochen-Spanne:

$21.51

$56.00

Avidity Biosciences Inc Stock (RNA) Company Profile

Firmenname

Avidity Biosciences Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (637)

Telefon

858-401-7900

Adresse

10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA

Mitarbeiter

391

Twitter

Nächster Verdiensttermin

2024-12-07

Neueste SEC-Einreichungen

RNA's Discussions on Twitter

Vergleichen Sie RNA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RNA Avidity Biosciences Inc	49.77	7.41B	10.12M	-280.49M	-188.51M	-2.89
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-17	Eingeleitet	Roth Capital	Buy
2025-07-10	Fortgesetzt	Goldman	Buy
2025-06-24	Eingeleitet	Bernstein	Outperform
2025-06-17	Eingeleitet	Wolfe Research	Outperform
2025-06-11	Eingeleitet	Raymond James	Strong Buy
2025-03-13	Eingeleitet	Citigroup	Buy
2025-03-12	Eingeleitet	BMO Capital Markets	Outperform
2025-03-07	Eingeleitet	Scotiabank	Sector Outperform
2024-12-20	Eingeleitet	H.C. Wainwright	Buy
2024-11-26	Eingeleitet	RBC Capital Mkts	Outperform
2024-09-24	Eingeleitet	Goldman	Buy
2024-08-28	Eingeleitet	Barclays	Overweight
2024-05-03	Eingeleitet	BofA Securities	Buy
2024-03-14	Eingeleitet	Cantor Fitzgerald	Overweight
2023-05-22	Hochstufung	Evercore ISI	In-line → Outperform
2023-03-31	Herabstufung	Evercore ISI	Outperform → In-line
2022-07-20	Eingeleitet	Chardan Capital Markets	Buy
2022-07-12	Eingeleitet	Raymond James	Strong Buy
2021-09-07	Eingeleitet	Evercore ISI	Outperform
2021-06-17	Eingeleitet	Needham	Buy
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2020-07-07	Eingeleitet	Cowen	Outperform
2020-07-07	Eingeleitet	Credit Suisse	Outperform
2020-07-07	Eingeleitet	SVB Leerink	Outperform
2020-07-07	Eingeleitet	Wells Fargo	Overweight

Alle ansehen

Avidity Biosciences Inc Aktie (RNA) Neueste Nachrichten

Oct 12, 2025

Chart based exit strategy for Avidity Biosciences Inc.Market Growth Review & Low Risk Entry Point Tips - newser.com

Oct 12, 2025

Oct 10, 2025

Avidity Biosciences Inc. stock daily chart insightsGap Down & Weekly Top Performers Watchlists - newser.com

Oct 10, 2025

Can Avidity Biosciences Inc. stock hit record highs againPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com

Oct 10, 2025

Oct 09, 2025

Avidity Biosciences (NASDAQ:RNA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Ranking Avidity Biosciences Inc. among high performing stocks via toolsWeekly Stock Recap & Weekly High Momentum Picks - newser.com

Oct 09, 2025

Oct 08, 2025

Is Avidity Biosciences Inc a good long term investmentMid Cap Growth Trends & Low Entry Capital Stocks - earlytimes.in

Oct 08, 2025

What drives Ball Corporation stock priceBlue Chip Stock Analysis & High Return Trading Portfolio - earlytimes.in

Oct 08, 2025

Avidity Biosciences’ Phase 2 Study on AOC 1001: A Potential Game-Changer for DM1 Treatment - TipRanks

Oct 08, 2025

Oct 07, 2025

Avidity Biosciences (NASDAQ:RNA) Insider Eric Mosbrooker Sells 6,562 Shares - MarketBeat

Oct 07, 2025

Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society - Sahm

Oct 07, 2025

Oct 06, 2025

Avidity Biosciences (RNA): Assessing Valuation Following Recent Positive Share Price Momentum - Yahoo Finance

Oct 06, 2025

Avidity Poised For Commercialization Transformation - San Diego Business Journal

Oct 06, 2025

Quantitative breakdown of Avidity Biosciences Inc. recent move2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com

Oct 06, 2025

Avidity Biosciences Inc. stock trendline breakdownPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com

Oct 06, 2025

Oct 05, 2025

Avidity Biosciences Inc Stock Analysis and ForecastStock Price Targets & 5 Stocks Every Investor Should Own - earlytimes.in

Oct 05, 2025

Combining machine learning predictions for Avidity Biosciences Inc.Buy Signal & Fast Moving Stock Watchlists - newser.com

Oct 05, 2025

Relative strength of Avidity Biosciences Inc. in sector analysisJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 04, 2025

Oct 03, 2025

Avidity Biosciences Stock Price, Quotes and Forecasts | NASDAQ:RNA - Benzinga

Oct 03, 2025

BofA Securities Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $65 - 富途牛牛

Oct 03, 2025

Can Avidity Biosciences Inc. hit a new high this monthEarnings Summary Report & Weekly Market Pulse Updates - newser.com

Oct 03, 2025

Real time scanner hits for Avidity Biosciences Inc. explainedBull Run & Technical Entry and Exit Alerts - newser.com

Oct 03, 2025

Is Avidity Biosciences Inc. building a consolidation baseJuly 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com

Oct 03, 2025

Oct 01, 2025

Avidity Biosciences Prices $600 Million Upsized Public Offering of Common Stock - Global Legal Chronicle

Oct 01, 2025

Avidity Biosciences Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 01, 2025

Sep 29, 2025

Avidity Biosciences (NASDAQ:RNA) Shares Down 7.6%Here's What Happened - MarketBeat

Sep 29, 2025